RxDoctor Payments Data

Vaagn Andikyan, MD

Gynecologic Oncology · Tampa, FLNPI 1881985414

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,000 of the $9,960 with a category attached, or 60.2%. Intuitive Surgical accounts for 75.2% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $7,546, more than ten times the $245 reported in 2019.

$9,960in general payments, 2019–2025

Across 51 payments — averaging $195.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • AstraZeneca$525
  • GSK$465
  • Medtronic$369
  • AbbVie$248
  • Coopersurgical, Inc.$199
  • plus $665 from 11 others
$269,454in research payments, 2019–2025

Across 1 payment — averaging $269,454 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$269K

What the payments were for

  • Consulting fees$95010%
  • Travel & lodging$8418%
  • Food & beverage$2,16922%
  • Education$6,00060%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,960 in reported general payments places this provider in the 70th percentile of 117 gynecologic oncology providers in Florida.

See all gynecologic oncology providers in Florida

Medicare billing

Part B allowed, 2024
$57,882
Medicare patients
125
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →